On the public citation graph
A Study of 3CLpros as Promising Targets against SARS-CoV and SARS-CoV-2
0 signed · 58 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/14651858.cd009390.pub2openalex-snapshot
Abacavir versus other nucleoside reverse transcriptase inhibitor (NRTI) backbone therapies for treatment of HIV infection
inferredcites →https://doi.org/10.1002/med.21475openalex-snapshot
Proteases and protease inhibitors in infectious diseases
inferredcites →https://doi.org/10.1002/prot.10613openalex-snapshot
A hierarchical approach to all‐atom protein loop prediction
inferredcites →https://doi.org/10.1016/j.antiviral.2020.104786openalex-snapshot
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
inferredcites →https://doi.org/10.1016/j.antiviral.2020.104857openalex-snapshot
A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19
inferredcites →https://doi.org/10.1016/j.bbrc.2004.04.098openalex-snapshot
Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate
inferredcites →https://doi.org/10.1016/j.brainres.2015.09.008openalex-snapshot
Involvement of AMPK, IKβα-NFκB and eNOS in the sildenafil anti-inflammatory mechanism in a demyelination model
inferredcites →https://doi.org/10.1016/j.celrep.2020.107940openalex-snapshot
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
inferredcites →https://doi.org/10.1016/j.csbj.2020.03.025openalex-snapshot
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
inferredcites →https://doi.org/10.1016/j.ijid.2020.01.050openalex-snapshot
Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak
inferredcites →https://doi.org/10.1016/j.imu.2020.100345openalex-snapshot
Molecular docking and dynamic simulations for antiviral compounds against SARS-CoV-2: A computational study
inferredcites →https://doi.org/10.1016/j.jiph.2020.10.015openalex-snapshot
Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach
inferredcites →https://doi.org/10.1016/j.lfs.2020.117831openalex-snapshot
Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach
inferredcites →https://doi.org/10.1016/j.virusres.2015.05.018openalex-snapshot
Prediction and biochemical analysis of putative cleavage sites of the 3C-like protease of Middle East respiratory syndrome coronavirus
inferredcites →https://doi.org/10.1016/s0140-6736(20)30211-7openalex-snapshot
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
inferredcites →https://doi.org/10.1021/acs.jproteome.0c00392openalex-snapshot
Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase, a Key Drug Target for COVID-19
inferredcites →https://doi.org/10.1021/jm050540copenalex-snapshot
Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects
inferredcites →https://doi.org/10.1021/jm051256oopenalex-snapshot
Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein−Ligand Complexes
inferredcites →https://doi.org/10.1038/nm.4306openalex-snapshot
The Drug Repurposing Hub: a next-generation drug library and information resource
inferredcites →https://doi.org/10.1038/s41401-020-0483-6openalex-snapshot
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients
inferredcites →https://doi.org/10.1038/s41421-020-0156-0openalex-snapshot
Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
inferredcites →https://doi.org/10.1038/s41467-020-18233-xopenalex-snapshot
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
inferredcites →https://doi.org/10.1038/s41467-020-18463-zopenalex-snapshot
Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis
inferredcites →https://doi.org/10.1038/s41598-020-66440-9openalex-snapshot
Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic
inferredcites →https://doi.org/10.1038/s41598-020-74050-8openalex-snapshot
The global population of SARS-CoV-2 is composed of six major subtypes
inferredcites →https://doi.org/10.1056/nejmoa2001017openalex-snapshot
A Novel Coronavirus from Patients with Pneumonia in China, 2019
inferredcites →https://doi.org/10.1080/07391102.2020.1842807openalex-snapshot
SARS-CoV-2 M pro inhibitors: identification of anti-SARS-CoV-2 M pro compounds from FDA approved drugs
inferredcites →https://doi.org/10.1080/1120009x.2020.1775424openalex-snapshot
Lopinavir/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection
inferredcites →https://doi.org/10.1080/14756366.2020.1801672openalex-snapshot
Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro
inferredcites →https://doi.org/10.1093/ofid/ofaa455openalex-snapshot
Preventive Efficacy of Tenofovir/Emtricitabine Against Severe Acute Respiratory Syndrome Coronavirus 2 Among Pre-Exposure Prophylaxis Users
inferredcites →https://doi.org/10.1126/science.abb3405openalex-snapshot
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
inferredcites →https://doi.org/10.1128/aac.00754-20openalex-snapshot
Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19
inferredcites →https://doi.org/10.1128/aac.00825-20openalex-snapshot
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production
inferredcites →https://doi.org/10.1128/aac.42.12.3218openalex-snapshot
ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease
inferredcites →https://doi.org/10.1128/aac.49.8.3153-3162.2005openalex-snapshot
Mechanism of Inhibition of Vaccinia Virus DNA Polymerase by Cidofovir Diphosphate
inferredcites →https://doi.org/10.1128/mbio.03705-21openalex-snapshot
The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters
inferredcites →https://doi.org/10.1155/2013/321460openalex-snapshot
Sildenafil (Viagra) Protective Effects on Neuroinflammation: The Role of iNOS/NO System in an Inflammatory Demyelination Model
inferredcites →https://doi.org/10.1186/1471-2334-14-480openalex-snapshot
Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature
inferredcites →https://doi.org/10.1371/journal.pone.0068347openalex-snapshot
The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase
inferredcites →https://doi.org/10.21203/rs.3.rs-94864/v1openalex-snapshot
Promising Acyclovir and its derivatives to inhibit the protease of SARS-CoV-2: Molecular Docking and Molecular Dynamics simulations
inferredcites →https://doi.org/10.2139/ssrn.3588829openalex-snapshot
Remdesivir Potently Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
inferredcites →https://doi.org/10.21467/preprints.30openalex-snapshot
Role of Zidovudine and Candesartan in the Novel SARS-CoV-2 Treatment Trials
inferredcites →https://doi.org/10.21577/0103-5053.20200106openalex-snapshot
Tenofovir Disoproxil Fumarate: New Chemical Developments and Encouraging in vitro Biological Results for SARS-CoV-2
inferredcites →https://doi.org/10.2807/1560-7917.es.2020.25.3.2000044openalex-snapshot
Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020
inferredcites →https://doi.org/10.3201/eid2607.200359openalex-snapshot
Early Introduction of Severe Acute Respiratory Syndrome Coronavirus 2 into Europe
inferredcites →https://doi.org/10.3390/computation8020053openalex-snapshot
Computational View toward the Inhibition of SARS-CoV-2 Spike Glycoprotein and the 3CL Protease
inferredcites →https://doi.org/10.3760/cma.j.issn.0254-6450.2020.02.003openalex-snapshot
[The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1016/j.bja.2022.04.004openalex-snapshot
Use of sildenafil in patients with severe COVID-19 pneumonitis
inferred← citeshttps://doi.org/10.1016/j.heliyon.2025.e41980openalex-snapshot
SARS-CoV-2 drug resistance and therapeutic approaches
inferred← citeshttps://doi.org/10.1016/j.jmgm.2026.109359openalex-snapshot
Inhibitory potential of Morus alba leaf extract and its phytoconstituent against SARS-CoV-2 main protease: An integrative in silico and in vitro analysis
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.1c00409openalex-snapshot
Perspectives on SARS-CoV-2 Main Protease Inhibitors
inferred← citeshttps://doi.org/10.21608/ha.2022.96907.1080openalex-snapshot
Coronavirus disease 2019-imposed multifaceted effect on male sexual function: An online screening study
inferred← citeshttps://doi.org/10.3390/ijms25105126openalex-snapshot
Prediction of Drug-Target Affinity Using Attention Neural Network
inferred← citeshttps://doi.org/10.3390/microorganisms11040927openalex-snapshot
Special Issue “SARS-CoV-2: Epidemiology and Pathogenesis”: Editorial
inferred← citeshttps://doi.org/10.3390/molecules26247458openalex-snapshot
Molecular Docking and Dynamics Investigations for Identifying Potential Inhibitors of the 3-Chymotrypsin-like Protease of SARS-CoV-2: Repurposing of Approved Pyrimidonic Pharmaceuticals for COVID-19 Treatment
inferred← citeshttps://doi.org/10.3390/v17081064openalex-snapshot
SARS-CoV-2 Infection and Antiviral Strategies: Advances and Limitations
inferred← citeshttps://doi.org/10.3934/microbiol.2023002openalex-snapshot
In vitro and in silico evaluation of antiretrovirals against SARS-CoV-2: A drug repurposing approach
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.